DUBLIN, Nov. 2, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rwh43x/blood_screening) has announced the addition of the "Blood Screening Market - Global Market Research 2015-2019" report to their offering.
About blood screening
The report forecasts the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.
The report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR
Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.
Key vendors
- Abbott Diagnostics
- bioMérieux
- Grifols
- Roche Diagnostics
Other prominent vendors
- Alere
- BD
- Beckman Coulter
- Bio-Rad Laboratories
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic
- Immunetics
- Lab21
- Meridian Bioscience
- OraSure
- Ortho Clinical Diagnostics
- Qiagen
- SeraCare
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Trinity Biotech
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by technology
Part 07: Market segmentation by product
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
Part 16: Appendix
For more information visit
http://www.researchandmarkets.com/research/rwh43x/blood_screening
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
